Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma

Jerrold L. Boxerman, MD, PhD, FACR, Chair
Kathleen Schmainda, PhD, Co-Chair (Zheng Zhang, PhD)